Sort
50,496 grants matching “lung cancer”
The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis
$627,604William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules
$627,525Marc Elliott Lenburg · Boston University Medical Campus · R01 · FY2017 · CA
Noninvasive imaging and blood biomarkers for personalized lung cancer immunotherapy
$627,344Ruijiang Li · Stanford University · R01 · FY2025 · CA
Disparities in access to and outcomes of cancer surgery for rural Medicare patients
$627,289Anna N. A. Tosteson · Dartmouth College · R01 · FY2023 · CA
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
$627,180Jaime L Matta · Ponce School Of Medicine · U54 · FY2022 · CA
Radiomics of NSCLC
$627,157Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2020 · CA
Chemoprevention of lung cancer with mitochondria-targeted honokiol
$627,013Ming You · Medical College Of Wisconsin · R01 · FY2018 · CA
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics
$626,963Phil Crews · University Of California Santa Cruz · R01 · FY2014 · CA
Label-Free Optical Redox Imaging for Pretreatment Prognosis of Early-Stage Triple Negative Breast Cancer
$626,956Lin Z Li · University Of Pennsylvania · R01 · FY2024 · CA
Computing, Optimizing, and Evaluating Quantitative Cancer Imaging Biomarkers
$626,891Sandy A Napel · Stanford University · U01 · FY2016 · CA
Immunotherapy via engineered therapeutic programs in tumors using RNA
$626,885Ron Weiss · Massachusetts Institute Of Technology · U01 · FY2023 · CA
Immunotherapy via engineered therapeutic programs in tumors using RNA
$626,885Ron Weiss · Massachusetts Institute Of Technology · U01 · FY2022 · CA
Sex Hormones in Pulmonary Arterial Hypertension
$626,833James E Loyd · Vanderbilt University Medical Center · P01 · FY2021 · HL
Development of a New Multiplexed Imaging Strategy for Immunoprofiling using Raman-Active Nanoparticles
$626,777Cristina L. Zavaleta · University Of Southern California · R01 · FY2025 · CA
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy
$626,652Dejana K Braithwaite · University Of Florida · R01 · FY2022 · CA
Comparative Effectiveness of Surgery vs Stereotactic Radiation Therapy for Stage I Lung Cancer
$626,649Benjamin D Kozower · Washington University · R01 · FY2023 · CA
Local microbiota signatures of pro-tumor immunity and checkpoint inhibition susceptibility in lung cancer
$626,640Leopoldo Nicolas Segal · New York University School Of Medicine · R37 · FY2023 · CA
Understanding Efficacy and Fe(II)-Promoted Activation of 1,2,4-Trioxolanes in Cancer
$626,596Eric Collisson · University Of California, San Francisco · R01 · FY2022 · CA
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
$626,593Stavros Garantziotis · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES
The UGT2A and 3A metabolizing enzymes and tobacco-related cancer risk
$626,582Philip Lazarus · Washington State University · R01 · FY2017 · ES
Advancing Digital Pathology through Novel Machine Learning Methodologies
$626,575Saeed Hassanpour · Dartmouth College · R01 · FY2023 · LM
Rhesus HHV-8 homologue in AIDS-related malignancies
$626,541Scott W Wong · Oregon Health & Science University · R01 · FY2014 · CA
The Effect of Diet and Nutrients on the Progression and Treatment of Prostate Can
$626,526George Thomas · University Of Cincinnati · U01 · FY2009 · CA
Automated Planning and Robotic Delivery of Needle Biopsies under CT Image Guidance
$626,522Michael Yip · University Of California, San Diego · R01 · FY2025 · CA
Adaptive Interventions for Smoking Cessation in Lung Cancer Screening Programs
$626,520Anne Joseph · University Of Minnesota · R01 · FY2016 · CA